Metraipolis › archive › dc_922a4e046c4e
Liraglutide combined with dapagliflozin treatment improves myocardial disease and endothelial dysfunction in T2DM mice — Europe PMC PMID:42394413
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42394413
- DOI
- 10.1111/jdi.70363
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-18T11:35:18.755Z
- SHA-256 of the archived text
c28482163c5e66f6bc6e0686abf413d71eee704e230643174485be78855dc1b9- Stable URL of this page
https://metraipolis.com/documento/dc_922a4e046c4e
How to cite
Liraglutide combined with dapagliflozin treatment improves myocardial disease and endothelial dysfunction in T2DM mice — Europe PMC PMID:42394413 — Europe PMC (en), https://europepmc.org/article/MED/42394413 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_922a4e046c4e (Metraipolis archive dc_922a4e046c4e, sha256 c28482163c5e66f6bc6e0686abf413d71eee704e230643174485be78855dc1b9)
BibTeX
@misc{dc922a4e046c4e,
title = {Liraglutide combined with dapagliflozin treatment improves myocardial disease and endothelial dysfunction in T2DM mice — Europe PMC PMID:42394413},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42394413},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_922a4e046c4e; sha256 c28482163c5e66f6bc6e0686abf413d71eee704e230643174485be78855dc1b9},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42394413. Agents can read the archived copy with the MCP tool read_document.